dosing when switching from semaglutide to tirzepatide What is the recommended dosage schedule for (GLP-1 receptor agonist) 0.5mg (dual GIP and GLP-1 receptor agonist)? Switching Semaglutide to Tirzepatide |

The content herein is not intended to be, act as, or replace medical advice or diagnosis for individual health conditions nor is it making evaluations as to the risks or benefits of particular preparations

Others require more carbohydrates to fuel intensive training sessions

These changes are typically indirect consequences of the weight loss process rather than a direct pharmacological effect of semaglutide itself

Less Common but Serious Risks Both drugs carry warnings for: Pancreatitis Gallbladder problems (gallstones) Kidney injury (often related to dehydration from GI side effects) Risk of thyroid C-cell tumors (based on animal studies)